Neuraxis NRXS
NYSE NRXS
$6.15 -0.12 (-1.91%)
As of: Aug 21, 2026 · 3:59 PM EDT

Neuraxis (NRXS) Notes Payables (2022 - 2025)

Neuraxis (NRXS) posted Notes Payables of $148293.0 for Q4 2025, down 24.21% sequentially from $195658.0 in Q3 2025, and down 3.8% YoY from $154152.0 in Q4 2024.

Neuraxis (NRXS) Notes Payables (2022 - 2025) Analysis & Trends

Neuraxis has reported Notes Payables for 4 years, with the latest figure at $148293.0 in Q4 2025.

  • Quarterly Notes Payables fell 3.8% year-over-year to $148293.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $148293.0 (down 3.8% YoY) and the FY2025 annual result came in at $148293.0, down 3.8% from the prior year.
  • Notes Payables eased to $148293.0 in Q4 2025 per NRXS's latest filing, from $195658.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $4.7 million in Q2 2024 and troughed at $84307.0 in Q1 2025.
  • A 4-year average of $936069.0 and a median of $174200.5 in 2023 frame the typical range for Notes Payables.
  • The sharpest annual moves came in 2024 and 2025: Notes Payables surged 107.85% in 2024, then sank 97.43% in 2025.
  • Over 4 years, Notes Payables stood at $1.7 million in 2022, then slumped by 91.47% to $148062.0 in 2023, then grew by 4.11% to $154152.0 in 2024, then slipped by 3.8% to $148293.0 in 2025.
  • According to Business Quant data, Notes Payables over the past three periods registered $148293.0, $195658.0, and $121433.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Neuraxis 74.54 Mn 66.21 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 148,293.00
Sep 30, 2025 195,658.00
Jun 30, 2025 121,433.00
Mar 31, 2025 84,307.00
Dec 31, 2024 154,152.00
Sep 30, 2024 147,688.00
Jun 30, 2024 4.73 Mn
Mar 31, 2024 1.30 Mn
Dec 31, 2023 148,062.00
Sep 30, 2023 194,249.00
Jun 30, 2023 2.28 Mn
Dec 31, 2022 1.74 Mn